/ PFE
/ Earnings
Pfizer (PFE) Beats Expectations in Q2 2025, Raises EPS Guidance
Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78.
August 05, 2025
Pfizer Reports Q1 2025: Revenue Down 8% y/y
Pfizer's Q1 2025 results indicate a sound earnings performance, with adjusted EPS surpassing expectations.
April 29, 2025
Pfizer (NYSE: PFE) Reports Better than Expected Q4 Results
Pfizer Inc. (NYSE: PFE) reported a strong performance for the fourth quarter of 2024, with revenues reaching $17.8 billion.
February 04, 2025
Pfizer Targets Up to $64B Revenue in 2025 Amid Strategic Cost Savings
Pfizer projects 2025 revenues between $61 billion and $64 billion, with a focus on cost savings and strategic initiatives to drive growth.
December 17, 2024
Pfizer Inc.’s Strong Q3 Performance: Beats Expectations with $1.06 EPS
Pfizer Inc. reported stellar third-quarter financial results, with revenues surging to $17.7 billion.
October 29, 2024More from The Tokenist / PFE
Back to 
